D-Index & Metrics Best Publications

Meletios A. Dimopoulos

National and Kapodistrian University of Athens
Greece

Medicine

Greece

2023

D-Index & Metrics D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines.

Discipline name Citations Publications World Ranking National Ranking

Medicine D-index 153 Citations 101,476 1,775 World Ranking 543 National Ranking 3

Research.com Recognitions

Awards & Achievements

2023 - Research.com Medicine in Greece Leader Award

2022 - Research.com Medicine in Greece Leader Award

Overview

What is he best known for?

The fields of study Meletios A. Dimopoulos is best known for:

Immune system
Antibody
Sepsis

His research ties Eosinopenia and Immunology together. His research ties Immunology and Eosinopenia together. Borrowing concepts from CD34, Meletios A. Dimopoulos weaves in ideas under Antibody. Many of his studies involve connections with topics such as Stem cell and CD34. His Stem cell study frequently links to related topics such as Genetics. He regularly links together related areas like Neutralizing antibody in his Genetics studies. His studies link Virology with Neutralizing antibody. His research on Virology frequently connects to adjacent areas such as Vaccination. He combines Vaccination and Antibody in his research.

His most cited work include:

Hematological findings and complications of COVID ‐19 (1153 citations)
The neutralizing antibody response post COVID-19 vaccination in patients with myeloma is highly dependent on the type of anti-myeloma treatment (92 citations)
How I treat Waldenström macroglobulinemia (47 citations)

What are the main themes of his work throughout his whole career to date

Meletios A. Dimopoulos connects Immunology with Lymphocyte in his study. His study connects Cohort and Internal medicine. In his research, he undertakes multidisciplinary study on Antibody and Gene. He incorporates Gene and Antibody in his research. His multidisciplinary approach integrates Multiple myeloma and Bortezomib in his work. His work often combines Bortezomib and Multiple myeloma studies. In his research, he performs multidisciplinary study on Disease and Immunity. While working in this field, Meletios A. Dimopoulos studies both Immunity and Vaccination. Borrowing concepts from Disease, Meletios A. Dimopoulos weaves in ideas under Vaccination.

Meletios A. Dimopoulos most often published in these fields:

Immunology (100.00%)
Internal medicine (82.35%)
Antibody (64.71%)

This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.

Best Publications

International Myeloma Working Group updated criteria for the diagnosis of multiple myeloma.

S. Vincent Rajkumar;Meletios A. Dimopoulos;Antonio Palumbo;Joan Blade.
Lancet Oncology (2014)

3617 Citations

International uniform response criteria for multiple myeloma

B. G. M. Durie;J.-L. Harousseau;J. S. Miguel;J. Blade.
Leukemia (2006)

3186 Citations

Criteria for the classification of monoclonal gammopathies, multiple myeloma and related disorders: a report of the International Myeloma Working Group

Robert A. Kyle;J. Anthony Child;Kenneth Anderson;Bart Barlogie.
British Journal of Haematology (2003)

2732 Citations

Bortezomib plus melphalan and prednisone for initial treatment of multiple myeloma.

Jesús F. San Miguel;Rudolf Schlag;Nuriet K. Khuageva;Meletios A. Dimopoulos.
The New England Journal of Medicine (2008)

2329 Citations

Lenalidomide plus Dexamethasone for Relapsed or Refractory Multiple Myeloma

Meletios Dimopoulos;Andrew Spencer;Michael Attal;H. Miles Prince.
The New England Journal of Medicine (2007)

1881 Citations

International Myeloma Working Group consensus criteria for response and minimal residual disease assessment in multiple myeloma

Shaji Kumar;Bruno Paiva;Kenneth C. Anderson;Brian Durie.
Lancet Oncology (2016)

1673 Citations

Osteonecrosis of the Jaw in Cancer After Treatment With Bisphosphonates: Incidence and Risk Factors

Aristotle Bamias;Efstathios Kastritis;Christina Bamia;Lia A. Moulopoulos.
Journal of Clinical Oncology (2005)

1501 Citations

Hematological findings and complications of COVID-19.

Evangelos Terpos;Ioannis Ntanasis-Stathopoulos;Ismail Elalamy;Efstathios Kastritis.
American Journal of Hematology (2020)

1380 Citations

Daratumumab, Lenalidomide, and Dexamethasone for Multiple Myeloma

Meletios A. Dimopoulos;Albert Oriol;Hareth Nahi;Jesus San-Miguel.
The New England Journal of Medicine (2016)

1345 Citations

Elotuzumab Therapy for Relapsed or Refractory Multiple Myeloma

Abstr Act;Sagar Lonial;Meletios Dimopoulos;Antonio Palumbo.
The New England Journal of Medicine (2015)

1318 Citations

If you think any of the details on this page are incorrect, let us know.

Frequent Co-Authors

External Links

Personal Website for Meletios A. Dimopoulos